Molecular Medicine - Structural Parasitology Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), Aruna Asaf Ali Marg, New Delhi, 110067, India.
Department of Medical Elementology and Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, 110062, India.
Chembiochem. 2021 Jul 15;22(14):2468-2477. doi: 10.1002/cbic.202100212. Epub 2021 May 28.
Plasmodium falciparum lysyl-tRNA synthetase (PfKRS) represents a promising therapeutic anti-malarial target. Cladosporin was identified as a selective and potent PfKRS inhibitor but lacks metabolic stability. Here, we report chemical synthesis, biological evaluation and structural characterization of analogues where the tetrahydropyran (THP) frame of cladosporin is replaced with the piperidine ring bearing functional group variations. Thermal binding, enzymatic, kinetic and parasitic assays complemented with X-ray crystallography reveal compounds that are moderate in potency. Co-crystals of Cla-B and Cla-C with PfKRS reveal key atomic configurations that allow drug binding to and inhibition of the enzyme. Collectively these piperidine ring scaffold inhibitors lay a framework for further structural editing and functional modifications of the cladosporin scaffold to obtain a potent lead.
疟原虫赖氨酸-tRNA 合成酶(PfKRS)是一个很有前途的抗疟治疗靶点。克拉多菌素被鉴定为一种选择性和有效的 PfKRS 抑制剂,但缺乏代谢稳定性。在这里,我们报告了克拉多菌素的四氢吡喃(THP)框架被带有官能团变化的哌啶环取代的类似物的化学合成、生物评价和结构特征。热结合、酶、动力学和寄生虫测定与 X 射线晶体学相结合,揭示了具有中等效力的化合物。与 PfKRS 的 Cla-B 和 Cla-C 的共晶揭示了允许药物结合和抑制酶的关键原子构型。这些哌啶环骨架抑制剂为进一步对克拉多菌素骨架进行结构编辑和功能修饰以获得有效先导化合物奠定了框架。